Download presentation
Presentation is loading. Please wait.
Published byClaude Stewart Modified over 8 years ago
1
Hybrid Off-Pump Revascularization; Early & Midterm Results 서울대학교병원 흉부외과 황 호영, 조 광리, 김 기봉
2
SNUH Thoracic and Cardiovascular Surgery Background Hybrid CABG CABG + PCI To achieve Complete revascularization w/ minimally invasive surgery
3
SNUH Thoracic and Cardiovascular Surgery Aims of This Study To evaluate Indications Early & Midterm results of hybrid CABG
4
SNUH Thoracic and Cardiovascular Surgery Patient Profiles 1998.01 - 2004.07 25 / 782 of total OPCAB pt (3.2%) Age (yr) 62.6 9.6 Sex (M : F)17 : 8 Unstable : Stable angina19 : 6 Three-vessel disease17 Combined left main stenosis6
5
SNUH Thoracic and Cardiovascular Surgery Patient Co-morbidity Hypertension14 DM10 CRF 4 Hypercholesterolemia 4 CVA9 Carotid artery stenosis1
6
SNUH Thoracic and Cardiovascular Surgery Hybrid CABG OPCAB w/ total arterial grafts Periop PCI Preop PCI (n=8)3.9 4.3 (d) Postop PCI (n=17)1.7 2.2 (d)
7
SNUH Thoracic and Cardiovascular Surgery Indication of Hybrid (I) Preop PCI + OPCAB N=8 Complete revasularization w/ minimally invasive surgery7 Emergent PCI for culprit lesion1
8
SNUH Thoracic and Cardiovascular Surgery Indication of Hybrid (II) OPCAB + postop PCIN=17 Unable to revascularize externallyn=9 1. Diffuse coronary atherosclerosis5 2. No more arterial conduit w/ ascending aorta calcification3 3. Intramyocardial coroanry artery1 Borderline lesion (70-90%) in big RCAn=8
9
SNUH Thoracic and Cardiovascular Surgery Coronary Lesions Treated by CABG Target Lesions# LAD24 OM or Ramus20 Diagonal9 PDA4 Total 57 (2.3 1.0/ pt)
10
SNUH Thoracic and Cardiovascular Surgery Coronary Lesions Treated by PCI Target Lesions# Left coronary territory9 LCX 7 OM 1 LM 1 Right coronary territory21 Proximal RCA 13 Mid RCA 3 Distal RCA 5 Total 30(1.2 0.4 /pt)
11
SNUH Thoracic and Cardiovascular Surgery Strategy Of Antipletelet Therapy Preop PCI + OPCAB Pre. PCI#1PCI #0-PreopPreop #1OpPostop #1- ASA 100mg CPD 600mg ASA 100mg CPD 75 mg Heparinization Intraop Heparin ASA 100mg CPD 75 mg OPCAB + Postop PCI PreopPreop #1OpPostop #1 (PCI)Maintain ASA 300mgHeparinization Intraop heparin ASA 100mg CPD 600mg ASA 100mg CPD 75 mg
12
SNUH Thoracic and Cardiovascular Surgery Results
13
SNUH Thoracic and Cardiovascular Surgery Postop Results Mortality0% (0/25) Complications related to surgery Transient Af5 Periop MI1 Transient ARF1 Complications related to PCI Periprocedural MI1
14
SNUH Thoracic and Cardiovascular Surgery Early Postop CAG Postop 1.8 1.6 (d) Graft patency: 100%(57/57) stenosis (>60%): none PCIrestenosis : 1 / 9 preop PCI : reballoon done
15
SNUH Thoracic and Cardiovascular Surgery Midterm Results F/U : 25.4 25.5 Mo Late death: 1 (d/t CHF) Follow up CAG 16/17 pt (F/U > 6 Mo) 9.6 3.0 Mo after hybrid CABG OPCAB patency100% (35/35) String sign of arterial graft (n = 1) Stent restenosis n = 2
16
SNUH Thoracic and Cardiovascular Surgery PCI Restenosis PCI#Restenosis Balloon only20 Bare metal stent122 (16.7%) DES50 Total192 (10.5%)
17
SNUH Thoracic and Cardiovascular Surgery Conclusions Hybrid OPCAB Combined procedures taking merits of CABG and PCI Effective method to obtain complete myocardial revascularization and excellent mid-term patency
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.